Lycia Therapeutics: 10% owner Trombley Aetna Wun received 443,586 shares

What happened Trombley Aetna Wun, a 10% owner, received an award of 443,586 shares on Aug 11, 2026. The filing reports the acquisition as derivative securities at $0.00 per share for a total reported value of $0.

Key details

• Transaction date and price: Aug 11, 2026; acquisition price $0.00 per share.
• Shares acquired: 443,586 shares (derivative).
• Shares owned after the transaction: not specified in the filing.
• Vesting and terms: the award vests 1/48 of the total monthly over 4 years, with the first tranche vested on Sep 6, 2026, subject to continued service (footnote F2).
• Regulatory note: the transaction occurred prior to the issuer's registration of the class of equity securities and is reported under Rule 16a-2(a) (footnote F1).
• Filing timeliness: the Form 4 was filed on Oct 26, 2026 for a transaction dated Aug 11, 2026; the filing was late.

Why it may matter

• This was a grant/award of derivative securities with a multi-year monthly vesting schedule, not an immediate open-market purchase or sale.
• The reporting person is a 10% owner, indicating a large holder position rather than an executive stock sale.
• A filing does not show why the insider traded or why the company acted.